-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Population-based data have explored the perianal involvement of Crohn’s disease (CD) and compared the course of severe and non-severe perianal CD (PCD).
Recently, an authoritative journal in the field of medsci.
medsci.
The researchers identified cases from the EpiII-IIRN cohort, which included two Israeli health maintenance organizations, covering 78% of the population.
Since 2005, a total of 12,904 CD patients have been included in the study (2186 [17%] pediatric cases), and 86,119 annual follow-ups have been completed.
diagnosis
Thus, although the immune higher utilization modulator and biological agents, but with a poor prognosis PCD disease, especially in patients with severe PCD .
Although the immune higher utilization modulator and biological agents, but with a poor prognosis PCD disease, especially in patients with severe PCD immune
Original source:
Original source:Ohad Atia.
Perianal Crohn's disease is associated with poor disease outcome: a nation-wide study from the epiIIRN cohort in this message